Evidence map›Paper›PMID 32196430›Full record

ReviewEmerging microbes & infections2020

Laboratory diagnosis of emerging human coronavirus infections - the state of the art.

Michael J Loeffelholz, Yi-Wei Tang

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Emerging microbes & infections, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04398043 (Searching for SARS-CoV 2 in Personal Protective Equipment in Physicians in a University Hospital), which is not on this map. Cited by 379 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
379citing papers in PubMed, 4 pooled it
19.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04398043 unknown statusnot on this map

Searching for SARS-CoV 2 in Personal Protective Equipment in Physicians in a University Hospital

TypeobservationalSponsorHospital de Clinicas José de San MartínRan2020 to 2020Enrolled16Conditionsrt PCR, COVID, Personal Protective Equipment PPE, SARS-CoV 2
3 · Its place in the literature

Who cites it

379 citing papers in PubMed, 4 syntheses or guidelines pooled it, 831 citations in OpenAlex.

  1. Thoracic imaging tests for the diagnosis of COVID-19.The Cochrane database of systematic reviews · 2022
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Thoracic imaging tests for the diagnosis of COVID-19.The Cochrane database of systematic reviews · 2021
    Pooled it
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

319 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 2 countries.

Michael J LoeffelholzCepheid, Sunnyvale, CA, USA.
Yi-Wei TangCepheid, Danaher Diagnostic Platform, Shanghai, People's Republic of China.
Danaher (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The three unprecedented outbreaks of emerging human coronavirus (HCoV) infections at the beginning of the twenty-first century have highlighted the necessity for readily available, accurate and fast diagnostic testing methods. The laboratory diagnostic methods for human coronavirus infections have evolved substantially, with the development of novel assays as well as the availability of updated tests for emerging ones. Newer laboratory methods are fast, highly sensitive and specific, and are gradually replacing the conventional gold standards. This presentation reviews the current laboratory methods available for testing coronaviruses by focusing on the coronavirus disease 2019 (COVID-19) outbreak going on in Wuhan. Viral pneumonias typically do not result in the production of purulent sputum. Thus, a nasopharyngeal swab is usually the collection method used to obtain a specimen for testing. Nasopharyngeal specimens may miss some infections; a deeper specimen may need to be obtained by bronchoscopy. Alternatively, repeated testing can be used because over time, the likelihood of the SARS-CoV-2 being present in the nasopharynx increases. Several integrated, random-access, point-of-care molecular devices are currently under development for fast and accurate diagnosis of SARS-CoV-2 infections. These assays are simple, fast and safe and can be used in the local hospitals and clinics bearing the burden of identifying and treating patients.

Indexed as

BetacoronavirusClinical Laboratory TechniquesAntigens, ViralCommunicable Diseases, EmergingCoronavirus InfectionsCOVID-19COVID-19 TestingCOVID-19 VaccinesDisease OutbreaksHumansPandemicsPneumonia, ViralPoint-of-Care TestingReal-Time Polymerase Chain ReactionReverse Transcriptase Polymerase Chain ReactionSARS-CoV-2Antigens, ViralCovid-19 aAPC vaccineCOVID-19 VaccinesCOVID-19Human coronavirusPOCTreal-time PCRSARS-CoV-2serology

Identifiers

PMID32196430
PMCPMC7172701
OpenAlexW3011420630

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.